Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
about
Nuclear actions of insulin-like growth factor binding protein-3Environmental chemical exposures and human epigeneticsIn silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas.Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma.MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia.Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors.Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling.Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesisInsulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer.IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.Chronic hepatitis B in hepatocarcinogenesisOncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer.Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells.CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus.Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage.Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin.
P2860
Q28080513-D6DF0635-6744-4F77-9597-595A9ABD027FQ28397621-0C59F77C-7EFA-48F6-B1D0-72C4426ECB88Q33282538-FEF8FCB9-3219-45C4-A7D3-091BEE8BEDEDQ33337232-0B5CDA8A-623C-4552-9DB3-A055DBB6F747Q33562658-CB16E1FB-A18C-4E89-9A3B-98288701228BQ33829462-0981B078-C3DB-45A2-8CC9-2F1EC59F78BFQ33855801-D4707F2D-E60B-4404-8441-6286E9020922Q34093124-C13C3BD8-655C-4ECC-B578-0040E81DE83EQ35859678-AA23A436-4DCC-43A6-A67F-5E8548432644Q35869171-848D17C0-6BEB-4F7E-B91D-C4D31B9D2B1FQ35987892-3115235D-1CF9-498C-B34B-2047EF85332AQ36094078-1119CACF-5989-479A-A40D-CA4D703FCBCFQ36259638-1EAEDF85-BFBE-4D3B-89B9-A5C693C3B64DQ36516208-745E7D5C-DF57-4C3A-B49F-E39A4FAADF85Q36557635-68490C9A-8EC5-4520-945E-8E875A909642Q37392638-69B90D6E-7E0D-49CD-BF9D-8A04F89E76B7Q38446849-0B008614-2076-4AA2-BB64-49536F8F1F6FQ38675999-23201324-58E4-46E2-ADA8-252CE4DCA592Q39051578-5FBB2CC2-4553-45CA-9453-70414DD816FBQ39224151-3134BCCF-98D9-45EF-A86F-2B1FFEB376CFQ39449572-848E0924-50EC-4183-878A-F4A3C3A2DD89Q40263710-54EFF044-A4B0-40D1-B93C-2DE2476DAC46Q42600588-9E7D8215-8FB9-45A8-8C72-DFC4E038CD90Q51021900-C973F709-E317-4020-A371-E658D4E8880F
P2860
Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Functional promoter upstream p ...... by tumor specific methylation
@ast
Functional promoter upstream p ...... by tumor specific methylation
@en
Functional promoter upstream p ...... by tumor specific methylation
@nl
type
label
Functional promoter upstream p ...... by tumor specific methylation
@ast
Functional promoter upstream p ...... by tumor specific methylation
@en
Functional promoter upstream p ...... by tumor specific methylation
@nl
prefLabel
Functional promoter upstream p ...... by tumor specific methylation
@ast
Functional promoter upstream p ...... by tumor specific methylation
@en
Functional promoter upstream p ...... by tumor specific methylation
@nl
P2093
P2860
P3181
P356
P1433
P1476
Functional promoter upstream p ...... by tumor specific methylation
@en
P2093
Eichiro Yumoto
Hidenori Shiraha
Kazuhiro Nouso
Norio Koide
Tadashi Hanafusa
Toshiro Ono
Toshiyuki Shinji
Yoshiaki Iwasaki
P2860
P2888
P3181
P356
10.1186/1471-2407-5-9
P407
P577
2005-01-20T00:00:00Z
P5875
P6179
1011688774